Skip to content

PanACEA

  • Contact us
  • Twitter
  • News
  • About Us
    • Mission
    • History
    • Governance
    • Donors
    • Scientific Network
  • Tuberculosis
    • Impact
    • Treatment
    • Drug development
  • Clinical Studies
    • Trial Design
    • PanACEA Studies
    • Vision for future Studies
  • Capacity Development

partners

Quintiles

Posted on September 17, 2013June 22, 2017 by admin
Posted in partners, Uncategorized

SVIZERA europe

Posted on July 25, 2013June 22, 2017 by admin
Posted in partners, Uncategorized

CLS

Posted on June 28, 2013June 22, 2017 by admin
Posted in partners, Uncategorized

Triclinium

Posted on May 17, 2013June 22, 2017 by admin
Posted in partners, Uncategorized

Sequella

Posted on May 17, 2013June 22, 2017 by admin
Posted in partners, Uncategorized

Clinical

Posted on May 17, 2013June 22, 2017 by admin
Posted in partners, Uncategorized

ACRO

Posted on May 17, 2013June 22, 2017 by admin
Posted in partners, Uncategorized

Recent Posts

  • PanACEA-SUDOCU-01 publication in the Lancet Infectious Diseases 08 July 2025
  • Podcast on TB drug development with Lilian Tina Minja and Norbert Heinrich for the Lancet
  • Dr Jodie Schildkraut
  • Dr. Laura Paramo MD
  • Staggered dosing of rifampicin using to minimise tolerability problems and maximize efficacy
© PanACEA
  • edctp
  • European Union

  • This project is part of the
    EDCTP2 programme supported
    by the European Union

  • Contact us
  • Twitter